e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Tumoural markers, prognosis, symptoms and palliation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical course of pneumonia in lung cancer
M. Taftadzhiyska, D. Karamanova, R. E. Petkov, W. Maksimov, A. Valeva (Sofia, Stara Zagora, Bulgaria)
Source:
Annual Congress 2005 - Tumoural markers, prognosis, symptoms and palliation
Session:
Tumoural markers, prognosis, symptoms and palliation
Session type:
Thematic Poster Session
Number:
2146
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Taftadzhiyska, D. Karamanova, R. E. Petkov, W. Maksimov, A. Valeva (Sofia, Stara Zagora, Bulgaria). Clinical course of pneumonia in lung cancer. Eur Respir J 2005; 26: Suppl. 49, 2146
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Clinical and bacteriological features of pneumonia associated with lung cancer (LC)
Source: Eur Respir J 2003; 22: Suppl. 45, 253s
Year: 2003
Lung cancer in long-lasting pneumonia
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Treatment and prognosis of lung cancer associated with interstitial pneumonia
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010
Clinical presentations of recurrent lung cancer after surgery
Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent
Year: 2007
Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008
Respiratory tuberculosis in lung cancer patients
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009
Clinical evaluation of patients with lung carcinoma
Source: Eur Respir J 2002; 20: Suppl. 38, 437s
Year: 2002
Clinical respiratory medicine: Treatment of lung cancer
Source: ERS Summit on priorities in respiratory medicine 2011
Year: 2011
Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan
Source: ERJ Open Res, 6 (2) 00184-2019; 10.1183/23120541.00184-2019
Year: 2020
Chronic eosinophilic pneumonia after radiation therapy for breast cancer
Source: Eur Respir J 2004; 23: 9-13
Year: 2004
Clinical problems in diagnosis of lung carcinoma
Source: Eur Respir J 2002; 20: Suppl. 38, 437s
Year: 2002
Prevalence and clinical characteristics of lung cancer with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 321s
Year: 2005
Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Clinical feature of elderly patients with lung cancer and COPD
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
Clinical impact of steps-count during hospitalization after surgery in lung cancer patients
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
Incidence of lung cancer among COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005
Clinical features and prognosis of multiple primary malignancies in patients with lung cancer
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept